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Abstract 
Although anaemia is recognised as a feature of colorectal cancer, the precise risk is 
unknown.  We performed a case-control study using electronic primary care records 
from the Health Improvement Network database, UK.  6,442 patients had a diagnosis 
of colorectal cancer, and were matched to 45,066 controls on age, sex, and practice. 
We calculated likelihood ratios and positive predictive values for colorectal cancer in 
both sexes, across 1g/dl haemoglobin and 10-year age bands, and examined features 
of iron deficiency. 
In men, 178(5.2%) of 3,421 cases and 47(0.2%) of 23,928 controls had a haemoglobin 
<9.0g/dl, giving a likelihood ratio (95% confidence interval) of 27(19,36). In women, 
the corresponding figures were: 227(7.5%) of 3,021 cases and 58(0.3%) of 21,138 
controls, a likelihood ratio of 41(30,61). Positive predictive values increased with age, 
and for each 1g/dl reduction in haemoglobin. The risk of cancer for current referral 
guidance was quantified. For men over 60 years with a haemoglobin <11g/dl and 
features of iron deficiency, the positive predictive value was 13.3%(9.7,18) and for 
women with a haemoglobin <10g/dl and iron deficiency, the positive predictive 
values was 7.7%(5.7,11). Current guidance for urgent investigation of anaemia misses 
some patients with a moderate risk of cancer, particularly men. 
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INTRODUCTION 
Iron-deficiency anaemia has long been recognised as a feature of colorectal 
cancer.(Goodman & Irvin, 1993) It is present in 11-57% of cancers,(Curless et al., 
1994; Majumdar et al., 1999; Roncoroni et al., 1999; Young et al., 2000) and is 
particularly suggestive of caecal tumours.(Dunne et al., 2002) Patients with anaemia 
as their presenting feature of cancer have worse staging(Gonzalez-Hermoso et al., 
2004) and mortality.(Stapley et al., 2006) Thus, referral of patients with iron-
deficiency anaemia for investigation of possible gastrointestinal blood loss is 
recommended. The main source of referral advice is the Referral Guidelines for 
Suspected Cancer.(NICE, 2005) These guidelines, updated in 2005 and sent to all UK 
general practitioners, suggest urgent referral for unexplained iron-deficiency anaemia, 
in a man of any age with a haemoglobin <11g/dl, or a non-menstruating woman with 
a haemoglobin <10g/dl. Different advice comes from the British Society of 
Gastroenterology (BSG) guidelines, which suggest investigation of iron-deficiency in 
men, and women over 50 or post menopausal, once the haemoglobin value is below 
the laboratory’s quoted normal range, but without suggesting a level of haemoglobin 
requiring urgent investigation.(Goddard et al., 2005) 
There is very little research evidence to guide the choice of a threshold haemoglobin 
warranting investigation. Only three studies have estimated the risk of colorectal 
cancer posed by iron-deficiency anaemia, and none for a specific threshold. The first 
study examined 695 patients referred for investigation under the BSG guidance and 
identified colorectal cancer in 6.3%. Cancer was more common in men, those over 50, 
and in those with a haemoglobin of 9.0g/dl or below.(James et al., 2005) The second 
examined 431 patients with iron-deficiency anaemia (haemoglobin below 12g/dl in 
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males and 11g/dl in females, with microcytosis) – 32 (7.4%) colorectal cancers were 
identified. (Logan et al., 2002) The degree of anaemia was not associated with the 
likelihood of cancer.(Yates et al., 2004) Finally, a smaller study in a single general 
practice followed a cohort of 26 patients with iron-deficiency anaemia for five years, 
with two colorectal cancers being discovered.(Stellon & Kenwright, 1997)  
Less clear is the need for investigation of anaemia without iron deficiency, or for iron 
deficiency without anaemia. In iron deficiency without anaemia, two studies have 
estimated that the risk of cancer is around five times the background risk.(Ioannou et 
al., 2002; Sawhney et al., 2007) Both these studies were based on small numbers of 
cancers, and were of patients already selected for investigation. 
A third study examined the primary care records of 349 colorectal cancer patients and 
1788 age and sex-matched controls, and calculated positive predictive values (PPVs) 
for colorectal cancer of 0.97% for haemoglobin values in the range 10.0-12.9 g/dl, 
and 2.3% for values below 10g/dl, but did not examine markers of iron-
deficiency.(Hamilton et al., 2005)  Conversely, patients with anaemia and a ferritin 
above 100ng/ml have a risk of cancer little above those neither anaemic nor iron 
deficient.(Sawhney et al., 2007)  
In the general population, anaemia is more common with increasing age. A large 
prevalence study was reported from the US in 2004, with anaemia defined as a 
haemoglobin <13.0g/dl in men and <12.0g/dl in women.(Guralnik et al., 2004) In the 
age group 50-64 years, 4.4% of men and 6.6% of women were anaemic; the 
percentage with anaemia increased progressively with each age band up to 85+ years, 
when 26.1% of men and 20.1% of women were anaemic.  
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The incidence of colorectal cancer also rises with age: annual rates per 100,000 in 50-
54 year olds are 44.7 in men and 33.1 in women; and respectively 504 and 323 aged 
85+.(Cancer Research UK, 2003) As both anaemia prevalence and colorectal cancer 
incidence rise with age, it is possible that the relative risk of colorectal cancer with 
anaemia is largely independent of age: this is a tacit assumption of current guidance. 
No study has been large enough to calculate the risk of colorectal cancer with anaemia 
for different ages, sexes, and haemoglobin values. This study aimed to address this 
evidence gap. 
 
METHODS 
We studied data from The Health Improvement Network (THIN), which uploads 
electronic medical records from GP practices using the VISION computer system. 
The records contain patient characteristics, all consultations, diagnoses and primary 
care investigations. The database has 2.2 million currently active patients in over 300 
practices: 4.7 million patients when historical data are included. Laboratory results 
have been transmitted electronically to most practices from the year 2000.  
 
Identification of cases and controls 
All patients with colorectal cancer were identified, who were aged 30 years or older, 
and diagnosed between January 2000 and July 2006. Up to seven controls were 
randomly selected for each case, using a computerised random numbers sequence. 
Controls were free from colorectal cancer and were matched for practice, sex and age. 
Where possible controls were born in the same year as cases; if none were available 
within one year of the cases, then the range was expanded to within two years, 
continuing to a maximum of five years. All participants had at least two years of 
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electronic records prior to the date of diagnosis of the case (the index date). The above 
stages of the data preparation were performed by THIN staff. 
 
Haemoglobin results taken in the year before the index date were studied. If more 
than one haemoglobin measurement had been taken, the final value was used for 
analysis. Mean cell volume (MCV) and ferritin results for the same year were also 
collated. Microcytosis was defined as an MCV <80.0fl, and a low ferritin as 
<20ng/ml.  
 
Analysis 
 
Associations between anaemia, microcytosis and low ferritin and colorectal cancer 
were estimated using multivariable conditional logistic regression. For the calculation 
of PPVs, haemoglobin values were stratified into six bands: below 9.0g/dl, and 1g/dl 
bands thereafter, up to 13.0g/dl. Age was stratified into four bands: 30-59 (there were 
too few cancers in this band for meaningful sub-division) and 10-year bands 
thereafter, up to 80+ years. The sexes were analysed separately. For each 
age/haemoglobin/sex triad we calculated the positive likelihood ratio with 95% 
confidence intervals from 2 2 tables. We used Bayes’ theorem (posterior odds = prior 
odds  likelihood ratio) to estimate PPVs.(Knottnerus, 2002) The prior odds were 
derived from national incidence rates stratified by age and sex for 2003, in that an 
annual incidence of (for example) 5 per 1000, is the equivalent of 199 to 1 odds 
against having cancer diagnosed in the next year.(Cancer Research UK, 2003) This 
was repeated for those patients with markers for iron-deficiency.  
As the number of cases was effectively pre-determined, a power calculation, rather 
than a sample size calculation, was performed. For an estimated 5000 cares, there was 
>99% power to detect 5% having haemoglobin values in a particular band, compared 
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with 1% amongst controls. These estimates were derived from the one previous 
primary care study.(Hamilton et al., 2005) Ethical approval was obtained from 
London MREC.  
 
RESULTS 
Between 1, January, 2000 and 31, July, 2006, there were 6,442 cases of colorectal 
cancer (3421 males; 3,021 females) recorded on the THIN database; 45,066 matched 
controls were available. Of these, 3,183 (49%) cases and 10,514 (23%) controls had a 
haemoglobin value measured in the year before the index date. Cases’ haemoglobin 
results were taken a median (inter-quartile range) of 62 (28,122) days before the index 
date; equivalent figures for controls were 134 (59,235) days. Details of the cases and 
controls are shown in Table 1, and the haemoglobin results in Table 2.  
 
 
Measurement of haemoglobin was more frequent in females; 6,870 females (28.4%) 
had a haemoglobin result compared with 6,827 males (25.0%); p<0.001, from a chi-
squared test. The positive likelihood ratios for each level of haemoglobin were 
relatively constant across the age bands. 
 
An MCV result was available for 12,599 (92%) and a ferritin was recorded in 1548 
(11%) of the 13,697 with a haemoglobin result. In cases, 764 (26%) of the 2,951 
MCV results showed microcytosis, and 353 (49%) of the 723 ferritin results were 
low. In controls, 210 (2.2%) of the 9,648 MCV results showed microcytosis, and 129 
(16%) of the 825 ferritin results were low.  
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In a multivariable conditional logistic regression model there were strong (p<0.001) 
independent associations with colorectal cancer for anaemia, microcytosis and a low 
ferritin: these are shown in Figure 1. There was an antagonistic interaction between 
microcytosis and low ferritin (interaction OR 0.25 (0.15, 0.43). 
 
PPVs for anaemia alone (irrespective of markers of iron-deficiency) are shown for the 
two sexes in Tables 3 and 4. For the subgroup who had markers of iron-deficiency, 
results are shown in Tables 5 and 6.  
 
The PPV for current recommendations was calculated for the over-60s; men with 
markers of iron-deficiency and a haemoglobin <11.0g/dl had a PPV of 13.3% (CI 9.7, 
18) and women with a haemoglobin <10.0g/dl 7.7% (5.7, 11). To allow comparison 
with the one previous primary care study, PPVs were calculated for two haemoglobin 
ranges, across all ages and both sexes. For haemoglobin results below 9.9g/dl, the 
PPV was 2.0% (CI 1.7, 2.3) and for 10.0-12.9g/dl the PPV was 0.3% (0.2, 0.3). 
 
 
DISCUSSION 
 
This is the first study large enough to estimate the risk of colorectal cancer across 
different ages, sexes and levels of haemoglobin. It confirms a strong association 
between anaemia and cancer, with the risk rising as the haemoglobin falls; it also 
confirms iron-deficiency as an independent predictor of cancer. The results can be 
used to guide individual doctors in deciding whether to refer patients with an 
abnormal haemoglobin result; they can also be used to improve current guidelines. 
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Strengths and weaknesses 
The study is large, with haemoglobin results from 13,757 primary care patients, 3,193 
of whom were to be diagnosed with colorectal cancer. Most of these results had been 
processed automatically, reducing the chance of inputting errors. We could not 
confirm the diagnoses of cancer, as histology results are not routinely logged on GPs’ 
computer systems; nevertheless, it is unlikely that such a serious diagnosis would be 
entered erroneously. Similarly, we could not identify alternative causes for anaemia, 
microcytosis or a low ferritin.  
 
A higher proportion of cases than controls had had their haemoglobin measured. We 
accommodated this within our calculation of PPVs, by using the national incidence 
figures for our prior odds, using the following equation: 
Posterior odds = likelihood ratio  prior odds (from the national incidence) 
One possibility is that differential rates of haemoglobin estimation made this 
calculation unreliable. The alternative was to study only those patients in whom a 
blood result was available. The difficulty with this approach is that the national 
incidence figures would not then pertain, as the simple fact of requesting testing of the 
haemoglobin selects a group in whom the risk of cancer is now twice the national risk 
– in that something, probably symptoms, triggered estimation of the haemoglobin.  
Posterior odds = LR of taking blood  LR of particular result  prior odds (national incidence) 
In this equation, the LR of taking blood was approximately 2, and the LRs of particular result were 
approximately half the LRs we quote in this paper. Thus, the effects cancel each other 
out.  However, by avoiding any bias from the different levels of testing between cases 
and controls, we had to make another assumption, namely that all untested patients 
had normal haemoglobin values. This is unlikely to be true, with untested cases 
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probably more likely to have undiagnosed anaemia than untested controls. If so, our 
PPVs are slight underestimates.  
 
We also only studied one feature – anaemia. Some patients may have had additional 
symptoms making a referral decision easy (or, conversely, may have an alternative 
explanation for the anaemia rendering referral unnecessary). It is likely that patients 
with accompanying symptoms would have higher PPVs (and conversely those with 
isolated anaemia have lower PPVs) than we have calculated. This may be less 
important that it appears: a common clinical problem in primary care (or any setting 
offering care to unselected patients) is of an unexpected finding of anaemia when 
colorectal cancer was not being considered, and the clinician has to decide how likely 
cancer is. Furthermore, current guidance uses only one variable: anaemia. To examine 
this guidance critically, we have to use the same single variable. Similarly, we studied 
only one diagnosis – colorectal cancer. Investigation of anaemia may be appropriate 
for other diagnoses, such as coeliac disease.(Cannings-John et al., 2007) This is 
incorporated into the BSG guidance. However, this does not change the value of our 
figures with respect to cancer, and their impact on cancer guidance. 
 
The overall PPVs in this study are lower than in the two studies performed in the 
referred population (which identified colorectal cancer in 6.3% and 7.4%).(James et 
al., 2005; Logan et al., 2002) However, they are similar to figures in the one previous 
primary care study, of 0.97% for a haemoglobin 10.0-12.9g/dl and 2.3% for 
haemoglobin <10.0g/dl in patients over 40 years.(Hamilton et al., 2005) This 
illustrates once again the higher risk in the referred population compared to the 
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primary care population as a whole, emphasising the need to use primary care data to 
guide primary care decisions.(Hamilton & Sharp, 2004) 
 
Comparison with current guidance 
One major problem with current guidance is that no threshold figure has been 
published for the risk of cancer warranting urgent investigation. Patients, doctors and 
commissioners will each have a viewpoint on this. The current cancer detection rate in 
UK rapid investigation clinics is 6-11%; however, these clinics only identify around a 
third of colorectal cancers.(Rai & Kelly, 2007) This reflects an important but 
awkward fact – less than half of patients with colorectal cancer have a high-risk 
symptom, such as rectal bleeding, with its PPV for cancer being 2.4-5.7%.(du Toit et 
al., 2006; Ellis & Thompson, 2005; Hamilton et al., 2005) The majority have softer 
symptoms, such as abdominal pain, constipation or diarrhoea, each with risks of 
cancer of around 1%.(Hamilton et al., 2005) If a higher proportion of symptomatic 
cancers are to be detected through rapid investigation clinics then a lower threshold 
risk – perhaps as low as 2% – has to be accepted. We consider most patients would 
wish to have urgent investigation with a risk of this magnitude. This is tacitly 
accepted by current guidance, in that referral for persistent diarrhoea is advised, even 
though the risk of cancer after two primary care attendances with diarrhoea is still 
quite low, at around 1.5%.(Hamilton et al., 2005) 
 
The current recommendations for anaemia (which require the presence of iron 
deficiency as well as anaemia) had PPVs of 13.3% for men and 7.7% for women. This 
clear sex difference remained for haemoglobin values above the current referral 
threshold. PPVs in men were above 4% for all haemoglobin values up to 12.0g/dl, 
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whereas women’s PPVs were generally lower. This reflects the higher overall 
incidence of colorectal cancer in men, together with the lower mean haemoglobin in 
all ages of women, not just those who are pre-menopausal.(Guralnik et al., 2004) 
Nonetheless, it can be argued that in patients with iron-deficiency, any degree of 
anaemia up to 12g/dl warrants urgent investigation (as the BSG guidance suggests, 
albeit without stating urgent investigation is warranted). Simpler guidance would be 
to ignore features of iron-deficiency entirely and recommend urgent referral of 
patients over 60 with unexplained anaemia on the haemoglobin value alone. If this 
were done, the current threshold figures of 11g/dl for men and 10g/dl for women 
appear reasonable, with almost all PPVs above 2%, and most well above this figure. 
 
This study provides an evidence base for investigation of anaemia detected in primary 
care. As always, there is a trade-off between identifying as many cancers as possible 
(sensitivity) and keeping the number of false-positives reasonable (specificity). 
Colorectal cancer generally presents with low-risk symptoms, so if earlier 
symptomatic diagnosis is to be achieved, lower specificity cannot be avoided. The 
current recommendations will miss some cancers, as the threshold haemoglobin 
figures are low. We recommend that the requirement for iron-deficiency is removed 
from current guidance, while the same threshold levels of haemoglobin are retained.  
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Table 1. Age and sex of cases and controls, in the whole cohort and in those with a 
haemoglobin estimation.   
 
 In whole cohort With a haemoglobin estimation 
 Number of 
Cases 
Number of 
Controls 
Number of 
Cases 
Number of 
Controls 
Age  Total 
(%) 
Males 
(%) 
Total 
(%) 
Males 
(%) 
Total 
(%) 
 
Total 
(%) 
 
30-59 1,179 
(18) 
648 
(55) 
8,254 
(18) 
4,537 
(55) 
489 (41)  1,158 (14)  
60-69       1,600 
(25) 
922 
(58) 
11,204 
(25) 
6,460 
(58) 
748 (47) 2,215 (20) 
70-79 2,127 
(33) 
1,180 
(55) 
14,901 
(33) 
8,272 
(56) 
1,085 (51) 3,823 (26) 
80+ 1,536 
(24) 
671 
(44) 
10,707 
(24) 
4,659 
(44) 
861 (56) 3,318 (31) 
Total 6,442 
(100) 
3,421 
(53) 
45,066 
(100) 
23,928 
(53) 
3,183  
(49) 
10,514  
(23) 
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Table 2. Haemoglobin results in cases and controls, by sex 
 
  
 
  
Males 
 
Females 
Haemoglobin 
band (g/dl) 
Number 
(%) in 
cases  
Number 
(%) in 
controls 
Positive 
likelihood 
ratio (CI) 
Number 
(%) in 
cases  
Number 
(%) in 
controls 
Positive 
likelihood 
ratio (CI) 
<9.0 178 
 (5.2) 
47  
(0.2) 
27 
(19, 36) 
221  
(7.3) 
36  
(0.2) 
43  
(30, 61) 
9.0-9.9        118  
(3.5) 
49  
(0.2) 
17 
(12, 23) 
146  
(4.8) 
85  
(0.4) 
12 
(9.2, 16) 
10.0-10.9 129  
(3.8) 
131  
(0.6) 
6.9 
(5.4, 8.8) 
226  
(7.5) 
225  
(1.1) 
7.0 
(5.9, 8.4) 
11.0-11.9 171  
(5.0) 
293  
(1.2) 
4.1 
(3.4, 4.9) 
238  
(7.9) 
616  
(2.9) 
2.7 
(2.3, 3.1) 
12.0-12.9 203  
(5.9) 
572  
(2.4) 
2.5 
(2.1, 2.9) 
289  
(9.6) 
1,337 
(6.3) 
1.5 
(1.3, 1.7) 
>12.9 805  
(23.5) 
4,131 
(17.3) 
1.4 
(1.3, 1.5) 
459  
(15.2) 
2,992 
(14.2) 
1.1 
(0.98, 1.2) 
Unmeasured 
 
1,817 
(53.1) 
18,705 
(78.2) 
 1,442 
(47.7) 
15,847 
(75.0) 
 
 
Total 
 
3,421 
 
23,928 
  
3,021  
 
21,138  
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Table 3. PPV for colorectal cancer of haemoglobin result taken in primary care, in 
males by age, expressed as a percentage (with 95% CIs).  
 
 
 
Age 
(years) 
Annual 
incidence of 
colorectal 
cancer in this 
age group 
 (%)(Cancer 
Research UK, 
2003) 
 
Haemoglobin (g/dl) 
<9.0 9.0 to 
9.9 
10.0 
to 
10.9 
11.0 
to 
11.9 
12.0 
to 
12.9 
 
13.0 
30-59 0.026 1.3 
 
0.4, 4.3 
1.4  
 
0.2, 10 
0.8 
 
0.3, 2.2 
0.8 
 
0.2, 2.9 
0.2 
 
0.1, 0.3 
0.1 
 
0.1, 0.1 
60-69 0.19 7.6 
 
3.4, 16 
7.2 
 
2.9, 17 
2.3 
 
1.1, 4.8 
1.4 
 
0.9, 2.3 
0.7 
 
0.5, 1.0 
0.3 
 
0.3, 0.3 
70-79 0.35 8.8 
 
5.4, 14 
4.0 
 
2.5, 6.3 
3.2 
 
2.2, 4.8 
1.5 
 
1.2, 2.0 
1.0 
 
0.7, 1.2 
0.4 
 
0.3, 0.4 
 80 0.43 6.8 
 
4.2, 11 
6.0 
 
3.4, 10 
1.6 
 
1.1, 2.2 
1.0 
 
0.8, 1.4 
0.6 
 
0.5, 0.8 
0.4 
 
0.3, 0.5 
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Table 4. PPV for colorectal cancer of haemoglobin result taken in primary care, in 
females by age, expressed as a percentage (with 95% CIs).  
 
Age 
(years) 
Annual 
incidence of 
colorectal 
cancer in this 
age group  
(%)(Cancer 
Research UK, 
2003) 
 
Haemoglobin (g/dl) 
<9.0 9.0 to 
9.9 
10.0 
to 
10.9 
11.0 
to 
11.9 
12.0 
to 
12.9 
 
13.0 
30-59 0.02 0.9 
 
0.3, 2.9 
0.3 
 
0.1, 0.6 
0.4 
 
0.2, 0.8 
0.1 
 
0.1, 0.2 
0.0 
 
0.0, 0.1 
0.0 
 
0.0, 0.0 
60-69 0.11 >5 
 
note 
2.7 
 
1.2, 5.9 
1.2 
 
0.7, 2.0 
0.4 
 
0.3, 0.6 
0.2 
 
0.1, 0.2 
0.1 
 
0.1, 0.2 
70-79 0.21 8.6 
 
5.4, 14 
3.6 
 
2.1, 6.0 
1.9 
 
1.4, 2.6 
0.5 
 
0.4, 0.6 
0.3 
 
0.3, 0.4 
0.2 
 
0.2, 0.2 
 80 0.27 7.1 
 
4.5, 11 
2.2 
 
1.5, 3.1 
1.2 
 
0.9, 1.5 
0.6 
 
0.5, 0.8 
0.3 
 
0.2, 0.4 
0.2 
 
0.2, 0.3 
 
Note: In the red-shaded cells for age bands 60-69, with a haemoglobin value below 9g/dl, 41 
cases but no controls, had this combination. Strictly, a likelihood ratio, and PPV, cannot be 
calculated when one cell is zero, but the PPV must be very high, so it has arbitrarily been set 
at >5%. 
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Table 5. PPV for colorectal cancer of haemoglobin result accompanied by indicators 
of iron-deficiency, in males by age, expressed as a percentage (with 95% CIs).  
 
 
Age 
(years) 
Annual 
incidence of 
colorectal 
cancer in this 
age group 
 (%)(Cancer 
Research UK, 
2003) 
 
Haemoglobin (g/dl) 
<9.0 9.0 to 
9.9 
10.0 
to 
10.9 
11.0 
to 
11.9 
12.0 
to 
12.9 
 
13.0 
60-69 0.19 >5 
 
note 
12 
 
3.1, 37 
5.5 
 
1.2, 21 
6.5 
 
2.0, 19 
1.8 
 
0.7, 4.2 
1.4 
 
0.6, 3.6 
70-79 0.35 18 
 
8.7, 34 
16 
 
6.3, 35 
14 
 
5.9, 29 
4.1 
 
2.1, 8.0 
3.9 
 
1.8, 8.5 
1.7 
 
0.9, 3.1 
 80 0.43 15 
 
7.3, 28 
31 
 
5.6, 77 
8.2 
 
3.7, 17 
4.0 
 
1.6, 9.3 
1.5 
 
0.5, 4.2 
1.4 
 
0.6, 3.1 
Note: for the age band 30-59, 64 cases, but only 11 controls, had markers of iron deficiency, 
making meaningful analysis impossible. In the red-shaded cell for age 60-69, with a 
haemoglobin value below 9g/dl, 30 cases but no controls had this combination. Again, a 
likelihood ratio, and PPV, cannot be calculated when one cell is zero, but the PPV must be 
very high, so it has arbitrarily been set at >5%. 
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Table 6. PPV for colorectal cancer of haemoglobin result accompanied by indicators 
of iron-deficiency, in females by age, expressed as a percentage (with 95% CIs).  
 
Age 
(years) 
Annual 
incidence of 
colorectal 
cancer in this 
age group  
(%)(Cancer 
Research UK, 
2003) 
 
Haemoglobin (g/dl) 
<9.0 9.0 to 
9.9 
10.0 
to 
10.9 
11.0 
to 
11.9 
12.0 
to 
12.9 
 
13.0 
30-59 0.02 0.6 
 
0.2, 2.2 
0.3 
 
0.1, 0.8 
0.6 
 
0.2, 2.1 
0.2 
 
0.1, 0.4 
0.1 
 
0.0, 0.3 
0.1 
 
0.0, 0.3 
60-69 0.11 >5 
 
note 
3.5 
 
1.1, 11 
2.4 
 
1.0, 5.7 
1.5 
 
0.7, 3.3 
0.1 
 
0.0, 0.8 
2.9 
 
0.6, 12 
70-79 0.21 10 
 
5.2, 19 
8.6 
 
3.8, 18 
5.9 
 
3.0, 11 
2.1 
 
1.1, 4.0 
0.8 
 
0.4, 1.7 
0.4 
 
0.2, 1.1 
 80 0.27 10 
 
5.6, 17 
5.7 
 
3.0, 11 
2.5 
 
1.5, 4.1 
3.6 
 
2.0, 6.5 
1.5 
 
0.5, 4.2 
0.8 
 
0.3, 1.8 
 
Note: In the red-shaded cell for age 60-69, with a haemoglobin value below 9g/dl, 36 cases 
but no controls had this combination. Again, a likelihood ratio, and PPV, cannot be calculated 
when one cell is zero, but the PPV must be very high, so it has arbitrarily been set at >5%. 
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Figure 1. Semi-logarithmic plot of odds-ratios for independent associations with colorectal 
cancer for different haemoglobin values and microcytosis and low ferritin results 
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